Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Rubik Therapeutics Logo
Rubik Therapeutics CB Rank
329601
Heat Score
60
Rubik Therapeutics is leveraging computational biology and genome-wide screens to develop engineered cell therapies for solid tumors.
Founded
obfuscation
PrivateSeed Boston, Massachusetts, United States1-10 www.rubiktherapeutics.com/
Biotechnology
Health Care
Therapeutics
Overview

Rubik Therapeutics
Heat Score
60

Growth Score
pts
in past quarter
Heat Score 60
-12 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About Rubik Therapeutics

CB Rank
329601
Rubik Therapeutics is leveraging computational biology and genome-wide screens to develop engineered cell therapies for solid tumors.
Founded
obfuscation
PrivateSeed Boston, Massachusetts, United States1-10 www.rubiktherapeutics.com/
Biotechnology
Health Care
Therapeutics

Funding Rounds

Seed
OBF
in
obfuscation

Key People

Details

Legal Name Rubik Therapeutics, Inc
Operating Status Active
Company Type For Profit
Founders  Murray Robinson
About the Company
Rubik Therapeutics is a platform therapeutics company developing next gen cell therapies for solid tumors. Rubik's computational engine and genome scale discovery tools have identified a set of unique genetic modulators that endow immune cells (T and NK) with potent and selective anti-tumor activity.
Contact Email INFO@RUBIKTHERAPEUTICS.COM
Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

Next-generation programmed cell therapies
Developing cell therapies that target highly selective, unique tumor targets and counteract immune suppression for solid tumors.
Proprietary platform
A discovery engine that codes discoveries in cancer and immune gene regulation to identify selective targets for cell therapy and other modalities.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Number of Funding Rounds 1
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Seed Round - Rubik Therapeutics Logo
Seed Round - Rubik Therapeutics
1
obfuscation
Illumina AcceleratorSeed
obfuscation
Seed Round - Rubik Therapeutics Logo
Seed Round - Rubik Therapeutics
1
obfuscation
Illumina AcceleratorSeed
obfuscation
Seed Round - Rubik Therapeutics Logo
Seed Round - Rubik Therapeutics
1
obfuscation
Illumina AcceleratorSeed
obfuscation
Seed Round - Rubik Therapeutics Logo
Seed Round - Rubik Therapeutics
1
obfuscation
Illumina AcceleratorSeed
obfuscation
Seed Round - Rubik Therapeutics Logo
Seed Round - Rubik Therapeutics
1
obfuscation
Illumina AcceleratorSeed

Funding Rounds

Number of Funding Rounds 1
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Seed Round - Rubik Therapeutics Logo
Seed Round - Rubik Therapeutics
1
obfuscation
Illumina AcceleratorSeed
obfuscation
Seed Round - Rubik Therapeutics Logo
Seed Round - Rubik Therapeutics
1
obfuscation
Illumina AcceleratorSeed
obfuscation
Seed Round - Rubik Therapeutics Logo
Seed Round - Rubik Therapeutics
1
obfuscation
Illumina AcceleratorSeed
obfuscation
Seed Round - Rubik Therapeutics Logo
Seed Round - Rubik Therapeutics
1
obfuscation
Illumina AcceleratorSeed
obfuscation
Seed Round - Rubik Therapeutics Logo
Seed Round - Rubik Therapeutics
1
obfuscation
Illumina AcceleratorSeed

Investors

Market Intelligence
People
View Profiles & Contacts
Headcount 1-10 Employee Profiles 1 Contacts 3

Employee Profiles

News
Technology
View Tech Report

IT Spend

$81.5KThis year, Rubik Therapeutics is projected to spend $81.5K on IT, according to Aberdeen.

Active Website Tech Count

21Rubik Therapeutics is actively using 21 technologies for its website, according to BuiltWith. These include IPhone / Mobile Compatible, Viewport Meta, and  SSL by Default.
Sub-Organizations
Frequently Asked Questions

Where is Rubik Therapeutics's headquarters? Rubik Therapeutics is located in Boston, Massachusetts, United States.Who invested in Rubik Therapeutics? Rubik Therapeutics is funded by Illumina Accelerator.When was the last funding round for Rubik Therapeutics? Rubik Therapeutics closed its last funding round on
obfuscation
from a Seed round.Who are Rubik Therapeutics's competitors? Alternatives and possible competitors to Rubik Therapeutics may include TScan Therapeutics, Obsidian Therapeutics, and  Lyell Immunopharma.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(53de11a 1)
|